Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2012
08/30/2012WO2012116328A2 Bad phosphorylation determines ovarian cancer chemo-sensitivity and patient survival
08/30/2012WO2012116248A1 ALTERNATIVELY SPLICED mRNA ISOFORMS AS PROGNOSTIC INDICATORS FOR METASTATIC CANCER
08/30/2012WO2012116185A1 Methods of detecting aneuploidy in human embryos
08/30/2012WO2012116040A1 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors in hepatocellular carcinoma
08/30/2012WO2012116034A1 Electrophoretic-deposited surfaces
08/30/2012WO2012116019A1 Compositions and methods for detecting bladder cancer
08/30/2012WO2012116001A2 Particles and other substrates useful in protein purification and other applications
08/30/2012WO2012115885A1 Circulating biomarkers
08/30/2012WO2012115851A1 Ultra-high sensitive monitoring of early transplantation failure
08/30/2012WO2012115820A2 Biomarker panels, diagnostic methods and test kits for ovarian cancer
08/30/2012WO2012115770A1 Apparatus and method for estimation of ore quality using color correlations
08/30/2012WO2012115648A1 Compositions and methods for diagnosing and treating kidney disorders in a feline
08/30/2012WO2012115604A1 Mean dna copy number of chromosomal regions is of prognostic significance in cancer
08/30/2012WO2012115493A2 Biomarker for cancer, and cancer diagnosis using same
08/30/2012WO2012115308A1 Method and apparatus for diagnosing thyroid cancer
08/30/2012WO2012115221A1 Method for measuring myocardial troponin
08/30/2012WO2012115185A1 Composition for treatment, amelioration or prophylaxis of pain
08/30/2012WO2012114932A1 Method of evaluating degree of skin stress accumulation
08/30/2012WO2012114708A1 Test substance detection method, and test substance detection chip and test substance detection device using same
08/30/2012WO2012114312A2 Exogenous internal positive control
08/30/2012WO2012114272A1 A method for the prognosis of progression of the hiv disease
08/30/2012WO2012114227A1 Biosensor and method of manufacturing such a biosensor
08/30/2012WO2012114056A1 Capacitance detection in electrochemical assay with improved response
08/30/2012WO2012114055A1 Capacitance detection in electrochemical assay with improved sampling time offset
08/30/2012WO2012114046A1 Arsenic assay using elisa
08/30/2012WO2012113986A1 Particle processing
08/30/2012WO2012113944A1 Apparatus for analysing vegetable products during the processing thereof
08/30/2012WO2012113921A1 Rapid selection method for hiv gp-120 variants
08/30/2012WO2012113911A1 Solid support and method of recovering biological material therefrom
08/30/2012WO2012113907A2 Paper support and method of recovering biological material therefrom
08/30/2012WO2012113906A2 Solid support and method of enhancing the recovery of biological material therefrom
08/30/2012WO2012113834A1 Method and use of metabolites for the diagnosis of inflammatory brain injury in preterm born infants
08/30/2012WO2012113819A1 Molecular biomarkers for predicting response to antitumor treatment in lung cancer
08/30/2012WO2012113801A1 Detection of antibodies using an improved immune complex (ic) elisa
08/30/2012WO2012113784A1 Diagnostic and therapeutic methods
08/30/2012WO2012113775A1 Ankyrin g and modulators thereof for the treatment of neurodegenerative disorders
08/30/2012WO2012113773A1 Diagnosis of ischemia using sflt-1 and hgf after intervention as an early indicator of complication
08/30/2012WO2012113760A1 Method of predicting the evolution of a patient suffering of stroke
08/30/2012WO2012113718A1 A diagnostic method for type ii diabetes
08/30/2012WO2012113555A1 Myh10 as a new diagnostic marker of pathologies resulting from runx1 inactivation
08/30/2012WO2012113519A1 Method for determining the content of hydrogen disulfide in crude and residual oils
08/30/2012WO2012113481A1 Method and apparatus for diagnosing electrodes in sensor elements
08/30/2012WO2012113371A1 Detection of dimeric catecholamine metabolites as indicators of neurodegenerative diseases
08/30/2012WO2012113266A1 Antibody and antigen recognizing tumor-initiating cells and use thereof
08/30/2012WO2012113061A1 Cancer diagnosis and treatment
08/30/2012WO2012113032A1 Method, system and apparatus for use in locating subsurface ore bodies
08/30/2012WO2012113028A1 Isolation of a target bioentity from a biological sample
08/30/2012WO2012113022A1 Therapeutic uses of slirp
08/30/2012WO2012094081A3 System and method for identifying and applying peripheral treatment mechanisms for disease
08/30/2012WO2012087928A3 Modulating agonistic tnfr antibodies
08/30/2012WO2012083132A3 Diagnosis and treatments relating to th2 inhibition
08/30/2012WO2012065099A3 Portable vacuum gas chromatograph
08/30/2012WO2012049228A3 Marker sequences for multiple sclerosis and the use thereof
08/30/2012WO2012048106A3 Biomarkers useful to predict mek inhibitor drug efficacy
08/30/2012WO2012047341A9 Sapp-alpha as a biomarker for prediction of inflammatory and autoimmune-related disorders
08/30/2012WO2012037486A9 Method and apparatus for encoding test strips
08/30/2012WO2012016107A8 Methods and kits for detection of salmonella enteritidis and related serovars
08/30/2012US20120222171 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
08/30/2012US20120222142 Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same
08/30/2012US20120222141 Islet1 (isl1) and hearing loss
08/30/2012US20120222139 Cancer Specific Mitotic Network
08/30/2012US20120221501 Molecular property modeling using ranking
08/30/2012US20120221291 Indoor testing device for a plurality of rotor-containing flying objects
08/30/2012US20120221256 Functional characterization of biological samples
08/30/2012US20120220914 Shrouded Sensor Clip Assembly and Blood Chamber for an Optical Blood Monitoring System
08/30/2012US20120220751 Non-Fluorescent Quencher Compounds and Biomolecular Assays
08/30/2012US20120220671 Use of galectin-3 for detecting and prognosing heart failure after acute coronary syndrome
08/30/2012US20120220661 Methods of modulation of branched chain acids and uses thereof
08/30/2012US20120220645 Genetic changes in atm and atr/chek1 as prognostic indicators in cancer
08/30/2012US20120220613 Method for determining sensitivity to an anticancer agent
08/30/2012US20120220610 Inhibitions of glutaminase c
08/30/2012US20120220540 Synbodies to akt1
08/30/2012US20120220534 Biomarker for neurodegeneration in neurological disease
08/30/2012US20120220532 Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
08/30/2012US20120220524 Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples
08/30/2012US20120220519 Peptide Aptamers that Bind to the Rep Proteins of ssDNA Viruses
08/30/2012US20120220495 Arrays of microparticles and methods of preparation thereof
08/30/2012US20120220493 Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and uses thereof
08/30/2012US20120220491 Retentate chromatography and protein chip arrays with applications in biology and medicine
08/30/2012US20120220490 Method and compositions for detecting botulinum neurotoxin
08/30/2012US20120220486 Methods and apparatus for binding assays
08/30/2012US20120220480 Method for the detection of renal damage
08/30/2012US20120220476 Biomarkers for ovarian cancer
08/30/2012US20120220471 Nanoantenna and uses thereof for biosensing
08/30/2012US20120220470 Diagnostic method for detecting cancer by measuring amount of a cytokine like il-6
08/30/2012US20120220469 Toxicity typing using liver stem cells
08/30/2012US20120220055 Method for Detecting Cardiac Ischemia via Changes in B-Natriuretic Peptide Levels
08/30/2012US20120220054 Device for detection of target molecules and uses thereof
08/30/2012US20120220052 Survival prognostic assay
08/30/2012US20120220051 Immunogenicity Assay
08/30/2012US20120220050 Method of purifying 8-isoprostane
08/30/2012US20120220049 Assay method and device
08/30/2012US20120220048 Magnetic marker particle and method for producing the same
08/30/2012US20120220043 Evidence collector with integral quantified reagents and method of modulating specimen drying time
08/30/2012US20120220042 Evidence collector with integral quantified reagents and method of modulating specimen drying time
08/30/2012US20120220038 Reagent kit for detecting lupus anticoagulant and method of determining presence or absence of lupus anticoagulant
08/30/2012US20120219987 Device for electroporation and lysis
08/30/2012US20120219980 System and method for pipetting guidance
08/30/2012US20120219977 Sequences, antibodies, methods and kits for detection and in vitro assay of periostin, in order to provide a diagnosis, follow-up or prognosis of diseases and biological phenomena involving periostin
08/30/2012US20120219976 Reducing the risk of human anti-human antibodies through v gene manipulation